OTCMKTS:TSOI

Therapeutic Solutions International - TSOI Stock Forecast, Price & News

$0.0028

0.00 (0.00%)

(As of 03/21/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.0027
▼
$0.0030
50-Day Range: $0.0028
▼
$0.0070
52-Week Range: $0.00
▼
$0.03

Volume: 9.58 million shs
Average Volume: 8.07 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

Headlines

SEC Filings

Short Interest

About Therapeutic Solutions International (OTCMKTS:TSOI) Stock

Therapeutic Solutions International, Inc. engages in the manufacture of surgical and medical devices. It develops a range of immune-modulatory agents to target cancers, enhance maternal and fetal health, and fight periodontal disease. The company was founded on August 6, 2007 and is headquartered in Elk City, ID.

Receive TSOI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Therapeutic Solutions International and its competitors with MarketBeat's FREE daily newsletter.

TSOI Stock News Headlines

March 20, 2023 | finance.yahoo.com

Therapeutic Solutions International Spin Off Campbell Neurosciences Creates Saliva Based Test for Suicidal Ideations

March 13, 2023 | finance.yahoo.com

Therapeutic Solutions International Advances Chronic Obstructive Pulmonary Disease Program by Identifying Novel B Regulatory Cell Mechanism of Action for JadiCell Universal Donor Adult Stem Cell

March 22, 2023 | Stansberry Research (Ad)

The gold catalyst we’ve waited for

If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.

March 6, 2023 | msn.com

Therapeutic Solutions plans to start breast cancer trial using FloraStilbene

March 6, 2023 | finance.yahoo.com

Therapeutic Solutions International Announces Plans to Initiate Breast Cancer Clinical Trial Using FloraStilbene™ Immune Stimulator Through Res Nova Bio Subsidiary

February 21, 2023 | finance.yahoo.com

Therapeutic Solutions International Launches Veltmeyer Institute for Advanced Biologics

February 14, 2023 | finance.yahoo.com

Res Nova Bio Leverages Immunological Similarities between Abortion Pill and Cancer Remission to Create Novel Immunotherapy

January 30, 2023 | finance.yahoo.com

Therapeutic Solutions International Spin Off Res Nova Bio Announces Recruitment of President and Chief Executive Officer

March 22, 2023 | Investing Daily (Ad)

How This Trader Banked A 97% Win Rate

Despite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself.

January 9, 2023 | finance.yahoo.com

Therapeutic Solutions International Identifies Novel Cellular Marker Associated with Therapeutic Response to JadiCell Stem Cell Treatment

January 4, 2023 | finance.yahoo.com

Therapeutic Solutions International Announces Antigen Specific Blockade of Pathological Immune Response in Multiple Sclerosis Model Using "Tattoo Gun" Immunization

December 5, 2022 | finance.yahoo.com

Therapeutic Solutions International Announces Improvements in Autism, Amyotrophic Lateral Sclerosis and Schizophrenia Cases Treated by Veltmeyer Institute for Advanced Therapeutics

November 28, 2022 | finance.yahoo.com

Therapeutic Solutions International Granted Broad Patent on Treatment of Neurodegenerative Conditions

November 14, 2022 | finance.yahoo.com

Therapeutic Solutions Announces Universal Donor Myeloid Derived Suppressor Therapy Platform for Treatment of Chronic Obstructive Pulmonary Disease (COPD)

November 9, 2022 | finance.yahoo.com

Therapeutic Solutions International Launches Spin-Off Breathe Biologics Aimed at Curing Chronic Obstructive Pulmonary Disease (COPD)

November 7, 2022 | finance.yahoo.com

Therapeutic Solutions International Spin-Off Res Nova Bio Collaborates with Veltmeyer MD Inc. to Provide Breast Cancer Patients Access to Novel Cancer Immunotherapy

October 27, 2022 | finance.yahoo.com

Therapeutic Solutions International Announces Launch of Cancer Immunotherapy Spin-Off Res Nova Bio, Inc.

October 24, 2022 | finance.yahoo.com

Therapeutic Solutions International Announces Successful Treatment of Epilepsy in Animal Model and Complete Cessation of Seizures in Treatment Resistant Patient

October 3, 2022 | finance.yahoo.com

Therapeutic Solutions International Identifies CD103 Expressing Dendritic Cells and Exosomes Thereof as Novel Mechanism for JadiCell Mesenchymal Stem Cell Mediated Lung Protection

September 20, 2022 | finance.yahoo.com

Therapeutic Solutions International Secures Financing to Complete Current Phase III Stem Cell Clinical Trial

September 19, 2022 | reuters.com

TSOI.PQ - Therapeutic Solutions International Inc | Stock Price & Latest News | Reuters

September 19, 2022 | finance.yahoo.com

Therapeutic Solutions International Spin-Off Company Campbell Neurosciences Announces Successful Preclinical Studies of CampbellCell for Treatment of Bipolar Disorder

September 3, 2022 | marketwatch.com

Therapeutic Drug Monitoring Market Size 2022 Global Growth, Trends, Industry Analysis, Key Players and Forecast to 2027 with CAGR of 9.8%

August 29, 2022 | finance.yahoo.com

Therapeutic Solutions International Develops Gene Silencing Therapy for Acute Respiratory Distress Syndrome

August 25, 2022 | finance.yahoo.com

Therapeutic Solutions International Files with FDA to Expand ongoing Phase III Clinical Trial to Include All Causes of Acute Respiratory Distress Syndrome

August 23, 2022 | marketwatch.com

Global NASH Therapeutic Drugs Market Size and Growth 2022 Analysis Report by Share, Growth Rate, Emerging Trends, and Forecast to 2028

August 16, 2022 | marketwatch.com

Therapeutic Enzymes Market Is Projected to RaIse a CAGR of 12.1% by 2027 | 91 Report Pages

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive TSOI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Therapeutic Solutions International and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:TSOI
CUSIP: 883378101
CIK: 1419051
Web: therapeuticsolutionsint.com
Phone: (760) 295-7208
Fax: N/A
Employees: 3
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Timothy G. Dixon
Chairman, President & Chief Executive Officer

James Veltmeyer
Chief Medical Officer

Feng Lin
Chief Scientific Officer

Famela Ramos
Vice President-Business Development

Serena Robella
Sales Director

Key Competitors

View All Competitors

TSOI Stock - Frequently Asked Questions

How have TSOI shares performed in 2023?: Therapeutic Solutions International's stock was trading at $0.0060 at the beginning of 2023. Since then, TSOI stock has decreased by 54.2% and is now trading at $0.0028.
View the best growth stocks for 2023 here.
Are investors shorting Therapeutic Solutions International?: Therapeutic Solutions International saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 92,100 shares, an increase of 79.5% from the February 13th total of 51,300 shares. Based on an average daily volume of 7,109,900 shares, the short-interest ratio is presently 0.0 days.
View Therapeutic Solutions International's Short Interest.
What other stocks do shareholders of Therapeutic Solutions International own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Therapeutic Solutions International investors own include Carnival Co. & (CCL), Korea Electric Power (KEP), Redwood Trust (RWT), Signet Jewelers (SIG), Goldman Sachs Physical Gold ETF (AAAU), Aurora Cannabis (ACB), AeroVironment (AVAV), Booking (BKNG), Chimera Investment (CIM) and Enterprise Products Partners (EPD).

What is Therapeutic Solutions International's stock symbol?: Therapeutic Solutions International trades on the OTCMKTS under the ticker symbol "TSOI."
How do I buy shares of Therapeutic Solutions International?: Shares of TSOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Therapeutic Solutions International's stock price today?: One share of TSOI stock can currently be purchased for approximately $0.00.
How can I contact Therapeutic Solutions International?: Therapeutic Solutions International's mailing address is 4093 Oceanside Blvd Ste B, OCEANSIDE, CA 92056-5816, United States. The official website for the company is therapeuticsolutionsint.com. The company can be reached via phone at (760) 295-7208.

This page (OTCMKTS:TSOI) was last updated on 3/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial